体内转染血管内皮生长因子基因对慢性低氧诱导小鼠肺动脉高压的影响

黄悦 兰江 胡蓉 高杰 李红 苏敏

解剖学报 ›› 2018, Vol. 49 ›› Issue (6) : 714-719.

PDF(360 KB)
欢迎访问《解剖学报》官方网站!今天是 English
PDF(360 KB)
解剖学报 ›› 2018, Vol. 49 ›› Issue (6) : 714-719. DOI: 10.16098/j.issn.0529-1356.2018.06.003
细胞和分子生物学

体内转染血管内皮生长因子基因对慢性低氧诱导小鼠肺动脉高压的影响

  • 黄悦1,2 兰江2 胡蓉2 高杰2 李红2 苏敏2,3*
作者信息 +

Effect of transfecting the vascular endothelial growth factor gene in vivo on the mice with pulmonary hypertension induced by chronic hypoxia

  • HUANG Yue 1,2 LAN Jiang2 HU Rong2 GAO Jie2 LI Hong2 SU Min 2,3*
Author information +
文章历史 +

摘要

目的 探讨血管内皮生长因子(Vegf)体内转基因对慢性低氧诱导小鼠肺动脉高压(PAH)的治疗作用。 方法 将昆明雄性小鼠36只随机分为3组:低氧Vegf治疗组(P-V组),模型组(PAH组),对照组(C组),每组12只。采用间断性常压缺氧法复制小鼠PAH模型。观察4周后,P-V组经尾静脉注射聚乙烯亚胺(PEI)包被的pBudCE4.1-Vegf-EGFP载体,其他组注射等量生理盐水,继续低氧处理。转基因治疗后30 d,观察小鼠的一般情况、平均肺动脉压(mPAP)、动脉血气、右心肥大指数[右心室/(左心室+室间隔)]及肺小动脉形态学改变,RT-PCR方法检测增强绿色荧光蛋白(EGFP)表达情况;Real-time PCR方法检测各实验组肺组织Vegf mRNA量; ELISA方法及硝酸还原酶法分别检测各实验组肺组织VEGF和NO含量。 结果 PAH组小鼠出现代谢性酸中毒,平均肺动脉压升高,右心室肥厚,肺小动脉管壁厚度(WT)增加,与C组相比,差异有统计学意义(P<0.05)。与PAH组相比,P-V组小鼠平均肺动脉压升高、右心室肥厚及肺小动脉管壁增厚减轻,差异有统计学意义(P<0.05)。与PAH组小鼠相比,P-V组小鼠外源基因Vegf的mRNA及蛋白水表达增加,差异有统计学意义(P<0.05)。 结论 Vegf转基因治疗能上调慢性低氧诱导小鼠的肺组织中Vegf mRNA和VEGF的表达,从而拮抗肺动脉压升高,减轻右心肥厚及肺动脉血管增厚。

Abstract

Objective To explore the therapeutic effect of transfecting the vascular endothelial growth factor (Vegf) gene in vivo on the mice with pulmonary hypertension induced by chronic hypoxia. Methods Thirty six male mice were randomly divided into 3 groups: P-V group, PAH group and control group, 12 mice per group. The mouse model was prepared using normal pressure intermittent hypoxia method. After four weeks, the mice in P-V group were transfected with pBudCE4.1-VegfEGFP by PEI-mediated in vivo, and the mice in other groups were treated with saline.Hypoxia was continued while transfection. The mean pulmonary artery pressure(mPAP), arterial gas analysis, right ventricular hypertrophy index[RV/(LV+S)] as well as pulmonary microvascular changes were observed after 30 days. The RT-PCR, Real-time PCR, ELISA, and nitrate reductase method were used in order to detect expression of EGFP, amount of Vegf mRNA, the level of VEGF and NO for pulmonary tissues, respectively. Results Compared with the control group, mPAP, right ventricular hypertrophy and wall thinckness (WT) increased in the PAH group (P<0.05). The extent of mPAP increasing,right ventricular hypertrophy and pulmonary artery WT had reduced in P-V group compared with the PAH group(P<0.05). Vegf mRNA,VEGF and NO protein expressions increased in lung tissue of the P-V group compared with the PAH group(P<0.05). Conclusion After transfecting the exogenous Vegf gene into mice, Vegf mRNA and protein expressions increased in the lung tissue of the mice, reduced the thickening of the small arteries and decreased the right ventricular hypertrophy index, and mPAP in mice of pulmonary hypertension induced by chronic hypoxia.

关键词

血管内皮生长因子 / 肺动脉高压 / 转染 / 基因治疗 / 实时定量聚合酶链反应 / 小鼠 

Key words

Vascular endothelial growth factor / Pulmonary arterial hypertension / Transfection / Gene therapy / Real-time PCR / Mouse

引用本文

导出引用
黄悦 兰江 胡蓉 高杰 李红 苏敏. 体内转染血管内皮生长因子基因对慢性低氧诱导小鼠肺动脉高压的影响[J]. 解剖学报. 2018, 49(6): 714-719 https://doi.org/10.16098/j.issn.0529-1356.2018.06.003
HUANG Yue LAN Jiang HU Rong GAO Jie LI Hong SU Min. Effect of transfecting the vascular endothelial growth factor gene in vivo on the mice with pulmonary hypertension induced by chronic hypoxia[J]. Acta Anatomica Sinica. 2018, 49(6): 714-719 https://doi.org/10.16098/j.issn.0529-1356.2018.06.003

参考文献

[1] Wang LT,Jing ZhCh.Development of new targeted drugs for pulmonary arterial hypertension[J]. Journal of International Pharmaceutical Research,2017,44(2):127-134. (in Chinese)
 王利婷,荆志成.肺动脉高压治疗药物研究进展[J]. 国际药学研究杂志,2017,44(2):127-134. 
 [2] Shi L,Zeng HP,Tang XY,et a1.An ultastructural study on effect of nypoxic pulmonary vascular in yong rats by heme-oxygenase/carbon-monoxide system[J].Acta  Anatomica  Sinica,2003,34(2):177-181. (in Chinese)
 石琳,曾和平,汤秀英,等.CO/HO体系影响缺氧性肺动脉高压幼年大鼠肺动脉超微结构研究[J]. 解剖学报,2003,34(2):177-181. 
 [3] Yoshida H,Kitaichi T,Urata M, et al.Syngeneic bone marrow mononuclear cells improve pulmonary arterial hypertension through vascular endothelial growth factor upregulation[J].Ann Thorac Surg,2009,88(2):418424.
 [4] Farkas L,Farkas D,Ask K,et al. VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats[J]. J Clin Invest, 2009,119(5):1298-1311.
 [5] Campbell AIM, Zhao Y, Sandhu R, et al. Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension[J]. Circulation, 2001,104(18):2242-2248.
 [6] Alagappan VK,de Boer WI,Misra VK,et al,Angiogenesis and vascular remodeling in chronic airway diseases[J].Cell Biochem Biophys,2013,67(2): 219-234. 
 [7] Zuo HB,Li CX,Guo ZhK.Relationship between cardiac function and angiogenesis after rat myocardial infarction[J]. Acta  Anatomica Sinica,2014,48(6):835-840. (in Chinese)
 左红波,李辞霞,郭志坤.大鼠心肌梗死后心功能变化与新生血管的关系[J].解剖学报,2014,48(6):835-840. 
 [8] Ogris M,Wagner E.Tumortargeted gene transfer with DNA polyplexes[J].Somat Cell Mol Genet,2002,27(16):85-95.
 [9] He HJ,Dai AG.Effects of feixin decoction on the contents of hypoxia-inducible factor-1α and vascular endothelial growth factor in the rat model of pulmonary arterial hypertension [J].Chinese Journal of Integrative Medicine, 2013,32(5):676-680.  (in Chinese)
 贺洪军,戴爱国.肺心汤对低氧性肺动脉高压模型大鼠低氧诱导因子-1α级血管内皮生长因子的影响[J].中国中西医结合杂志,2013,32(5):676-680. 
 [10] Boussif O,Zanta MA,Mergny MD,et a1.A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine[J].Proc Natl Acad Sci USA,1995,92 (16):7297-7301.
 [11]  Xue QF,Xie JM,Shao MG,et a1.Establishment of hypoxic pulmonary hypertension model in rats with hypoxic stress[J].Acta Academiae Medicina Sinica,1988,10(6):415.  (in Chinese)
 薛全福,谢剑鸣,邵茂刚,等.常压缺氧性大鼠肺动脉高压模型的建立[J].中国医学科学院学报,1988,10(6):415.
 [12] Voelke1 NF,Coo1 C,Taraceviene-Stewart L,et a1.Janus faceof vascular endothelial growth factor:the obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension[J].Crit Care Med,2002,30(5):251-256.
 [13] Li MX,Wang Y,Jiang DQ,et al.Advances in research on signal transduction mechanisms and their inhibitors for the proliferation of pulmonary artery smooth muscle cells[J].Chin Pharmacol Bull,2015,31(5):605-610.
 [14] Yamamoto A,Takahashi H,Kojima Y,et al.Downregulation of angiopoietin-1 and Tie2 in chronic hypoxic pulmonary hypertension[J].Respiration,2008,75(3):322-332.
 [15] Santos S,Peinado VI,Ramirez J,et al.Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2003,167(9):1250-l256.
 [16] Partovian C,Adnot S,Raffestin B,et al. Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats[J]. Am J Respir Cell Mol Biol, 2000,23(6):762-771.
 [17] Bates DO.Vascular endothelial growth factors and vascular permeability[J].Cardiovascu Res,2010,87(2):262-271.

基金

贵州医科大学贵阳市科技局联合基金;贵州省科技厅项目

PDF(360 KB)

Accesses

Citation

Detail

段落导航
相关文章

/